Background: Asthma is a common respiratory disease worldwide. However, few reports are available on the prevalences of asthma and asthma symptoms among Asian subjects. Methods: To determine the prevalences of asthma and asthma symptoms among Japanese subjects, we performed a nationwide cross-sectional, population-based study on Japanese adults aged 20–79 years. Ten areas spread throughout the country were randomly selected. Door-to-door or postal surveys were performed using a translated version of the European Community Respiratory Health Survey questionnaire. Results: The survey was completed by 23,483 participants. The overall response rate was 70.6%. The prevalences of wheeze and current asthma among all participants aged 20–79 years were 10.1% (95% CI: 9.7–10.5%) and 4.2% (95% CI: 4.0–4.5%), respectively. The prevalences among young adults aged 20–44 years were 9.3% (95% CI: 8.7–9.9%) and 5.3% (95% CI: 4.8–5.8%), respectively. The prevalence of current asthma was highest in females aged 30–39 years in comparison with the other gender and age groups. Conclusions: This nationwide study determined the prevalences of asthma and asthma symptoms among Japanese adults. The results provide fundamental information on the respiratory health of Japanese adults.

Keywords:
Asthma, Prevalence, Epidemiology, Japan
1.
The Global Initiative for Asthma: Global burden of asthma. http://www.ginasthma.com/ReportItem.asp?l1=2&l2=2&intId=94 (accessed December 30, 2009).
2.
Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996;9:687–695.
3.
Chan-Yeung M, Zhan LX, Tu DH, Li B, He GX, Kauppinen R, Nieminen M, Enarson DA: The prevalence of asthma and asthma-like symptoms among adults in rural beijing, china. Eur Respir J 2002;19:853–858.
4.
Dejsomritrutai W, Nana A, Chierakul N, Tscheikuna J, Sompradeekul S, Ruttanaumpawan P, Charoenratanakul S: Prevalence of bronchial hyperresponsiveness and asthma in the adult population in Thailand. Chest 2006;129:602–609.
5.
de Marco R, Zanolin ME, Accordini S, Signorelli D, Marinoni A, Bugiani M, Lo Cascio V, Woods R, Burney P: A new questionnaire for the repeat of the first stage of the European Community Respiratory Health Survey: a pilot study. Eur Respir J 1999;14:1044–1048.
6.
Watanabe J, Taniguchi M, Takahashi K, Nakagawa T, Ooya Y, Akazawa A, Akiyama K: Validation of ECRHS questionnaire in Japanese to use for nation-wide prevalence study of adult asthma (in Japanese). Arerugi 2006;55:1421–1428.
7.
Janson C, Chinn S, Jarvis D, Burney P: Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey. Eur Respir J 1997;10:1795–1802.
8.
Eder W, Ege MJ, von Mutius E: The asthma epidemic. N Engl J Med 2006;355:2226–2235.
9.
Norrman E, Plaschke P, Bjornsson E, Rosenhall L, Lundback B, Jansson C, Lindholm N, Boman G: Prevalence of bronchial hyper-responsiveness in the southern, central and northern parts of Sweden. Respir Med 1998;92:480–487.
10.
Manfreda J, Sears MR, Becklake MR, Chan-Yeung M, Dimich-Ward H, Siersted HC, Ernst P, Sweet L, Van Til L, Bowie DM, Anthonisen NR: Geographic and gender variability in the prevalence of bronchial responsiveness in Canada. Chest 2004;125:1657–1664.
11.
Leynaert B, Bousquet J, Henry C, Liard R, Neukirch F: Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study. Am J Respir Crit Care Med 1997;156:1413–1420.
12.
Sunyer J, Basagana X, Burney P, Anto JM: International assessment of the internal consistency of respiratory symptoms. European Community Respiratory Health Study (ECRHS). Am J Respir Crit Care Med 2000;162:930–935.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.